Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
919.37M
Market cap919.37M
Price-Earnings ratio
20.82
Price-Earnings ratio20.82
Dividend yield
Dividend yield
Average volume
993.32K
Average volume993.32K
High today
$28.52
High today$28.52
Low today
$27.27
Low today$27.27
Open price
$27.59
Open price$27.59
Volume
686.30K
Volume686.30K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$25.47
52 Week low$25.47

Stock Snapshot

The current Collegium Pharmaceutical(COLL) stock price is $28.23, with a market capitalization of 919.37M. The stock trades at a price-to-earnings (P/E) ratio of 20.82.

During the trading session on 2026-08-15, Collegium Pharmaceutical(COLL) shares reached a daily high of $28.52 and a low of $27.27. At a current price of $28.23, the stock is +3.5% higher than the low and still -1.0% under the high.

Trading activity shows a volume of 686.3K, compared to an average daily volume of 993.32K.

The stock's 52-week range extends from a low of $25.47 to a high of $50.79.

The stock's 52-week range extends from a low of $25.47 to a high of $50.79.

COLL News

Investing.com 2d
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com

...

Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
TipRanks 2d
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Seeking Alpha 2d
Collegium gains on $50M accelerated share buyback program

Collegium Pharmaceutical (COLL) traded higher in the premarket on Thursday after the ADHD drugmaker announced an accelerated share repurchase agreement with Jef...

Collegium gains on $50M accelerated share buyback program

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.